文献速递临床试验与 GCP

HOPON试验:高压氧预防放射性颌骨坏死的随机对照试验方案

HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible: study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2018-01-10

HOPON试验为III期多中心随机对照试验,评估高压氧(Marx方案)预防放疗后下颌骨高风险的牙科操作所致放射性颌骨坏死的获益。受试者为接受至少50 Gy放疗后需行高风险牙科操作者,1:1随机分组,主要终点为术后6个月放射性颌骨坏死。

要点

  • HOPON为III期多中心随机对照试验,采用非盲设计,主要终点由盲法专家小组评估。
  • 入组条件为下颌骨接受至少50 Gy放疗后需行高风险牙科操作者。
  • 两组均接受抗生素和氯己定漱口水,试验组加用高压氧(Marx方案)。

核心结论

  • HOPON试验旨在评估高压氧预防放疗后下颌骨手术所致放射性颌骨坏死的获益。

研究设计与样本

  • HOPON为III期、随机对照、多中心试验,采用非盲设计,主要终点由盲法专家小组基于匿名临床照片和影像学资料评估。
  • 受试者为下颌骨接受至少50 Gy放疗后需行高风险牙科操作者,按1:1随机分为高压氧组(Marx方案)与对照组,两组均接受抗生素和氯己定漱口水。

主要发现

  • 主要终点为术后6个月时放射性颌骨坏死的发生情况。
  • 次要终点包括其他时间点、急性症状与疼痛、生活质量,以及种植体植入后的成功留存情况。

关键数值与推荐

  • 入组条件为下颌骨需行高风险牙科操作且该区域接受至少50 Gy放疗。
  • 高压氧组采用Marx方案。
  • 主要终点为术后6个月放射性颌骨坏死。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteoradionecrosis of the mandible is the most common serious complication of radiotherapy for head and neck malignancy. For decades, hyperbaric oxygen has been employed in efforts to prevent those cases of osteoradionecrosis that are precipitated by dental extractions or implant placement. The evidence for using hyperbaric oxygen remains poor and current clinical practice varies greatly. We describe a protocol for a clinical trial to assess the benefit of hyperbaric oxygen in the prevention of osteoradionecrosis during surgery on the irradiated mandible. METHODS/DESIGN: The HOPON trial is a phase III, randomised controlled, multi-centre trial. It employs an unblinded trial design, but the assessment of the primary endpoint, i.e. the diagnosis of osteoradionecrosis, is assessed on anonymised clinical photographs and radiographs by a blinded expert panel. Eligibility is through the need for a high-risk dental procedure in the mandible where at least 50-Gy radiotherapy has been received. Patients are randomised 1:1 to hyperbaric oxygen arm (Marx protocol) : control arm, but both groups receive antibiotics and chlorhexidine mouthwash. The primary endpoint is the presence of osteoradionecrosis at 6 months following surgery, but secondary endpoints include other time points, acute symptoms and pain, quality of life, and where implants are placed, their successful retention. DISCUSSION: The protocol presented has evolved through feasibility stages and through analysis of interim data. The classification of osteoradionecrosis has undergone technical refinement to ensure that robust definitions are employed. The HOPON trial is the only multi-centre RCT conducted in this clinical setting despite decades of use of hyperbaric oxygen for the prevention of osteoradionecrosis. TRIAL REGISTRATION: European Clinical Trials Database, ID: EudraCT200700622527 . First registered on 5 November 2007.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Shaw R, Butterworth C, Tesfaye B, et al. HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible: study protocol for a randomised controlled trial. Trials. 2018. PMID: 29316962. doi:10.1186/s13063-017-2376-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。